Showing 6,009 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

New & experimental HIV treatments

Gilead Announces 96-Week Results From Phase 3 Study of Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 in Adults New to HIV Therapy

Editor's pick
Gilead press release
3 October 2018
Smoking

People living with HIV underestimate the harm of smoking

News
3 October 2018
New & experimental HIV treatments

HIV drug Symtuza® receives NHS England funding

Editor's pick
Pharmafield
28 September 2018
The search for a cure

Powerful antibodies suppress HIV for months, could simplify treatment

Editor's pick
Science
28 September 2018
How HIV works

PET Scans May Predict Who Gets Inflammatory Reaction to HIV Treatment Start

Editor's pick
Poz
26 September 2018
The search for a cure

Proof-of-concept HIV immunotherapy study passes Phase 1 safety trial

Editor's pick
Science Daily
24 September 2018
New & experimental HIV treatments

European advisory group backs Merck's HIV meds Delstrigo and Pifeltro

Editor's pick
Seeking Alpha
24 September 2018
New & experimental HIV treatments

NIH launches study to test combination antibody treatment for HIV infection

Editor's pick
National Institutes of Health
21 September 2018
PrEP policies & guidelines

US doctors’ organisation endorses event-based PrEP for the first time

News
19 September 2018
New & experimental HIV treatments

ViiV Healthcare submits regulatory application to European Medicines Agency for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV

Editor's pick
ViiV press release
16 September 2018
Retention & linkage to care

Stigma remains a substantial barrier in accessing HIV care in rural East Africa

News
14 September 2018
New & experimental HIV treatments

Doravirine Sets a New Standard for NNRTIs — But What Role in HIV Treatment Today?

Editor's pick
NEJM Journal Watch
13 September 2018
Resistance

Uganda:15 Percent HIV-Positive Ugandans Resistant to Drugs - Report

Editor's pick
AllAfrica
13 September 2018
New & experimental HIV treatments

Two new doravirine pills approved in US

News
12 September 2018
Child developmental issues

Developmental problems of children born to women with HIV linked to substance use and HIV, not antiretrovirals

News
11 September 2018
New & experimental HIV treatments

DNA technology provides novel strategy for delivery of complex anti-HIV agent

Editor's pick
Science Daily
6 September 2018
New & experimental HIV treatments

Elpida™ Included in Essential Drugs List for HIV-1 in Russia

Editor's pick
PR Newswire (press release)
6 September 2018
Money

Unstable housing associated with low CD4 cell count and detectable viral load for HIV-positive women in US

News
6 September 2018
Treatment guidelines

Focus on HIV-2 Infection: A Clinician Roundtable

Editor's pick
Infectious Disease Advisor
4 September 2018
Improving HIV care

Indonesia: tackling HIV in one of the world’s fastest-growing epidemics

News
4 September 2018
Pharmaceutical industry

Chasing top HIV players, Merck scores FDA approval for 2 new drugs

Editor's pick
FiercePharma
1 September 2018
New & experimental HIV treatments

FDA Approves Pair of HIV-1 Once-Daily Therapies from Merck

Editor's pick
MD Magazine
30 August 2018
Palliative care

Appropriate pain management may have role in key HIV treatment outcomes, suggests US research

News
30 August 2018
Treatment simplification strategies

What you need to know about HIV two-drug regimens

Editor's pick
BETA blog
28 August 2018